<DOC>
	<DOCNO>NCT00728286</DOCNO>
	<brief_summary>The purpose study assess platelet dependent thrombogenicity patient acute coronary syndrome use ex vivo arterial injury model .</brief_summary>
	<brief_title>Assessment Thrombogenicity Acute Coronary Syndrome</brief_title>
	<detailed_description>Abnormal platelet activity see patient Type2 Diabetes Mellitus ( T2DM ) may important contributor enhance cardiovascular risk high rate cardiovascular event follow acute coronary syndrome , despite dual antiplatelet therapy aspirin clopidogrel . We earlier demonstrated high thrombogenicity individual T2DM CAD absence acute ischaemic event , despite therapeutic dos aspirin.We hypothesise patient T2DM increase thrombogenicity acute coronary syndrome despite optimal secondary prevention medication.Measuring ex vivo thrombus area use arterial injury model simulate plaque rupture reflect summative effect haemostatic abnormality . The thrombus area patient ACS T2DM compare control without T2DM .</detailed_description>
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<mesh_term>Acute Coronary Syndrome</mesh_term>
	<criteria>Acute coronary syndrome ( WHO criteria ) raise cardiac troponin T Aged 1880 year Stable Acute coronary syndrome On aspirin clopidogrel Willing participate study Smoking ( current smoker smoker quit last 6 month precede recruitment ) Malignancy ( suspect proven ) Haematological disorder ( bleed disorder ) Premenopausal woman Use corticosteroids/other antithrombotic agent ( warfarin ) Chronic liver disease Unable consent</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>October 2015</verification_date>
	<keyword>Type 2 Diabetes Mellitus</keyword>
	<keyword>Acute Coronary Syndrome</keyword>
	<keyword>Platelet dependent thrombogenicity</keyword>
</DOC>